Our Computational Biology Team is composed of experts in bioinformatics, statistics, and data science who work on managing and analyzing large multi-omics datasets to improve targeting and efficacy in genomic medicine. We leverage our extensive biomarker Atlas, containing single-cell data from all human organs. By integrating this data with advanced computational analysis, we identify cell surface receptors uniquely expressed on disease-relevant cell types, unlocking new vector binding targets. Our deep understanding of cell-specific expression signatures and regulatory motifs also enables us to design optimized therapeutic payloads.
Our Protein and Vector Engineering Team addresses the challenges of targeted delivery in genomic medicine by designing viral and non-viral vectors for precise cell-type specificity. By integrating our in-depth knowledge of structural biology, sophisticated machine learning techniques, and a comprehensive understanding of ligand-target interactions, we design next-generation therapeutic vehicles with enhanced efficacy and reduced off-target effects.